Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma. (2021)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41392-021-00702-4
PubMed Identifier: 34482361
Publication URI: http://europepmc.org/abstract/MED/34482361
Type: Journal Article/Review
Volume: 6
Parent Publication: Signal transduction and targeted therapy
Issue: 1
ISSN: 2059-3635